AMSTERDAM, THE NETHERLANDS, October 11th, 2019 – Quantib, leader in Medical Imaging AI solutions, and Amsterdam UMC announce their partnership to develop and validate AI software in a joint venture with University Medical Center Utrecht, named Quantib-U. As part of the deal, Amsterdam UMC will provide access to data and allocate one of its top AI Medical Imaging scientists to projects within Quantib-U on a part-time basis. Quantib is now backed by the three largest radiology practices* of The Netherlands together providing unique insights into new use cases, broad data access and user feedback in a multi-center setting.
“Truly successful adoption of new AI software will only happen if we co-create with top clinicians and AI researchers”, says Arthur Post Uiterweer, CEO of Quantib and Quantib-U. “ With this partnership it now only takes a few weeks to develop and deploy new AI prototypes for clinical validation in three top clinical centers.”
Amsterdam UMC is a top clinical center, the largest in The Netherlands, and very interested in the new options that AI developments provide in healthcare. Additionally, Amsterdam UMC is happy to establish this collaboration with Quantib, which will allow Amsterdam UMC, through its AI Medical Imaging team, to contribute to the creation of better solutions for the benefit of patients.
Quantib, a leader in medical AI software, strives for faster and more accurate diagnoses, supporting adequate and timely patient care. Its products can detect changes in tissue sooner than would be possible with the naked eye. Quantib has multiple products cleared by FDA and CE marked, which are focused on quantification of neurodegenerative disease. It has a strong pipeline of new products focused on oncology and osteoarthritis.
For more information: Quantib.com
About Amsterdam Medical Center
At Amsterdam UMC, more than 15,000 professionals strive to provide good and accessible care for the generations of today and tomorrow, working together towards a future in which we prevent illnesses and make the best treatment available to all patients. To this end, we develop new methods for diagnostics and treatment together with professionals from other renowned national and international institutions. We treat over 350,000 patients a year at both our sites – AMC and VUmc. Our main focus is on complex patient care and highly-specialized treatment of rare medical conditions. At Amsterdam UMC, we teach and train thousands of young people to become doctors, specialists or nurses. Our researchers are clustered in eight research centers so that we can achieve our ambition of executing international, cutting-edge research. At Amsterdam UMC, AMC and VUmc are working together on academic patient care, scientific research and teaching & training.
*Erasmus Medical Center and University Medical Center Utrecht joined Quantib earlier in a partnership.